JP6175426B2 - 修飾依存的活性アッセイ - Google Patents

修飾依存的活性アッセイ Download PDF

Info

Publication number
JP6175426B2
JP6175426B2 JP2014511600A JP2014511600A JP6175426B2 JP 6175426 B2 JP6175426 B2 JP 6175426B2 JP 2014511600 A JP2014511600 A JP 2014511600A JP 2014511600 A JP2014511600 A JP 2014511600A JP 6175426 B2 JP6175426 B2 JP 6175426B2
Authority
JP
Japan
Prior art keywords
factor
recombinant
less
antibody
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2014511600A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524010A (ja
JP2014524010A5 (enExample
Inventor
ヴェーバー，アルフレート
エンゲルマイヤー，アンドレア
シュヴァルツ，ハンス，ペーター
Original Assignee
バクスアルタ ゲーエムベーハー
バクスアルタ ゲーエムベーハー
バクスアルタ インコーポレイテッド
バクスアルタ インコーポレイテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by バクスアルタ ゲーエムベーハー, バクスアルタ ゲーエムベーハー, バクスアルタ インコーポレイテッド, バクスアルタ インコーポレイテッド filed Critical バクスアルタ ゲーエムベーハー
Publication of JP2014524010A publication Critical patent/JP2014524010A/ja
Publication of JP2014524010A5 publication Critical patent/JP2014524010A5/ja
Application granted granted Critical
Publication of JP6175426B2 publication Critical patent/JP6175426B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • G01N33/6857—Antibody fragments
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2440/00—Post-translational modifications [PTMs] in chemical analysis of biological material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
JP2014511600A 2011-05-18 2012-05-18 修飾依存的活性アッセイ Active JP6175426B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161487612P 2011-05-18 2011-05-18
US61/487,612 2011-05-18
PCT/US2012/038704 WO2012159084A1 (en) 2011-05-18 2012-05-18 Modification-dependent activity assays

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017079848A Division JP2017161536A (ja) 2011-05-18 2017-04-13 修飾依存的活性アッセイ

Publications (3)

Publication Number Publication Date
JP2014524010A JP2014524010A (ja) 2014-09-18
JP2014524010A5 JP2014524010A5 (enExample) 2015-07-02
JP6175426B2 true JP6175426B2 (ja) 2017-08-02

Family

ID=46208807

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2014511600A Active JP6175426B2 (ja) 2011-05-18 2012-05-18 修飾依存的活性アッセイ
JP2017079848A Pending JP2017161536A (ja) 2011-05-18 2017-04-13 修飾依存的活性アッセイ
JP2018210141A Active JP6863950B2 (ja) 2011-05-18 2018-11-08 修飾依存的活性アッセイ
JP2020208021A Active JP7242627B2 (ja) 2011-05-18 2020-12-16 修飾依存的活性アッセイ
JP2023035124A Active JP7618714B2 (ja) 2011-05-18 2023-03-08 修飾依存的活性アッセイ

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2017079848A Pending JP2017161536A (ja) 2011-05-18 2017-04-13 修飾依存的活性アッセイ
JP2018210141A Active JP6863950B2 (ja) 2011-05-18 2018-11-08 修飾依存的活性アッセイ
JP2020208021A Active JP7242627B2 (ja) 2011-05-18 2020-12-16 修飾依存的活性アッセイ
JP2023035124A Active JP7618714B2 (ja) 2011-05-18 2023-03-08 修飾依存的活性アッセイ

Country Status (11)

Country Link
US (1) US8785139B2 (enExample)
EP (3) EP3943939A1 (enExample)
JP (5) JP6175426B2 (enExample)
AU (2) AU2012255066B2 (enExample)
CA (1) CA2836103C (enExample)
DK (2) DK2710375T3 (enExample)
ES (2) ES2720138T3 (enExample)
PL (2) PL3517956T3 (enExample)
PT (2) PT2710375T (enExample)
TR (1) TR201904997T4 (enExample)
WO (1) WO2012159084A1 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102375055A (zh) * 2010-08-19 2012-03-14 中国人民解放军军事医学科学院微生物流行病研究所 一种多重检测免疫层析芯片
US10745737B2 (en) * 2012-11-09 2020-08-18 Children's Medical Center Corporation Methods and reagents for glycoproteomics
CN103819907B (zh) * 2014-03-10 2016-04-06 山东理工大学 一种用聚丙二醇与聚乙烯醇对聚肽膜亲水性进行改进的方法
WO2015169602A1 (en) * 2014-05-05 2015-11-12 Noviosmart Method for the serological diagnosis of rheumatoid arthritis.
CN104559207B (zh) * 2015-01-05 2017-02-22 山东理工大学 一种聚氨基甲酸酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104559206B (zh) * 2015-01-05 2017-02-22 山东理工大学 一种聚三亚甲基碳酸酯与聚丙烯酰胺改进聚肽膜亲水性与柔顺性的方法
CN104448841B (zh) * 2015-01-06 2016-08-31 山东理工大学 一种聚乳酸乙醇酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104448843B (zh) * 2015-01-06 2016-10-05 山东理工大学 一种聚己内酯与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104448842B (zh) * 2015-01-06 2016-08-31 山东理工大学 一种聚乳酸与聚丙烯酸改进聚肽膜亲水性与柔顺性的方法
CN104559224B (zh) * 2015-01-12 2017-02-22 山东理工大学 一种聚丙二醇与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法
CN104530722B (zh) * 2015-01-12 2017-05-03 山东理工大学 一种聚乳酸乙醇酸与羧甲基壳聚糖改进聚肽膜亲水性与柔顺性的方法
CN104479367B (zh) * 2015-01-12 2016-08-31 山东理工大学 一种聚乳酸与水性聚氨酯改进聚肽膜亲水性与柔顺性的方法
US9804170B2 (en) 2015-02-09 2017-10-31 Bristol-Myers Squibb Company Antibodies to polyethylene glycol
JP6552286B2 (ja) * 2015-06-05 2019-07-31 公立大学法人奈良県立医科大学 凝固第ｖｉｉｉ因子の複合体形成能に関する情報の取得方法および試薬キット
SG11202107497XA (en) 2019-01-23 2021-08-30 Regeneron Pharma Treatment of ophthalmic conditions with angiopoietin-like 7 (angptl7) inhibitors
US11845989B2 (en) 2019-01-23 2023-12-19 Regeneron Pharmaceuticals, Inc. Treatment of ophthalmic conditions with angiopoietin-like 7 (ANGPTL7) inhibitors
CN110118847B (zh) * 2019-05-17 2021-08-10 重庆派金生物科技有限公司 确定多位点peg修饰蛋白质修饰位点的分析方法
EP4298219A1 (en) 2021-02-26 2024-01-03 Regeneron Pharmaceuticals, Inc. Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (angptl7) inhibitors
WO2023021311A1 (en) * 2021-08-20 2023-02-23 Takeda Pharmaceutical Company Limited Selective measurement of human factor viii
CA3244889A1 (en) 2022-03-08 2023-09-14 Equashield Medical Ltd FLUID TRANSFER STATION IN A ROBOTIC PHARMACEUTICAL PREPARATION SYSTEM

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3244030A1 (de) 1982-11-27 1984-05-30 Behringwerke Ag, 3550 Marburg Chromogene verbindungen, verfahren zu ihrer herstellung und ihre verwendung
US5208148A (en) 1990-12-07 1993-05-04 Molecular Probes, Inc. Lipophilic fluorescent glycosidase substrates
EP0603266B1 (en) 1991-08-23 1999-05-12 Molecular Probes, Inc. Use of haloalkyl derivatives of reporter molecules to analyze metabolic activity in cells
US5576424A (en) 1991-08-23 1996-11-19 Molecular Probes, Inc. Haloalkyl derivatives of reporter molecules used to analyze metabolic activity in cells
US5242805A (en) 1991-08-23 1993-09-07 Molecular Probes, Inc. Long wavelength lipophilic fluorogenic glycosidase substrates
US5830912A (en) 1996-11-15 1998-11-03 Molecular Probes, Inc. Derivatives of 6,8-difluoro-7-hydroxycoumarin
US5773236A (en) 1997-04-25 1998-06-30 Molecule Probes, Inc. Assay for glutathiane transferase using polyhaloaryl-substituted reporter molecules
CN1688248A (zh) * 2002-08-22 2005-10-26 贝克顿·迪金森公司 痴呆相关神经疾病的诊断方法
US8133865B2 (en) 2006-12-27 2012-03-13 Nektar Therapeutics von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkage
US9333247B2 (en) * 2007-07-03 2016-05-10 Children's Hospital & Research Center At Oakland Oligosialic acid derivatives, methods of manufacture, and immunological uses
ES2587742T3 (es) * 2007-12-27 2016-10-26 Baxalta GmbH Métodos para diferenciar en una muestra proteína derivada de plasma de proteína recombinante
ES2515365T3 (es) * 2007-12-27 2014-10-29 Baxter International Inc. Procedimiento y composiciones para detectar específicamente moléculas poliméricas fisiológicamente aceptables
BRPI0911266A2 (pt) * 2008-04-03 2015-09-29 Hoffmann La Roche ensaio de fator de crescimento similar à insulina peguilado
CA2740904C (en) * 2008-10-21 2019-01-15 Baxter International Inc. Methods for determining active ingredients in pro-drug peg protein conjugates with releasable peg reagents (in vitro de-pegylation)
US8642737B2 (en) 2010-07-26 2014-02-04 Baxter International Inc. Nucleophilic catalysts for oxime linkage
EP3081233B1 (en) 2009-07-27 2020-12-23 Baxalta GmbH Glycopolysialylation of proteins other than blood coagulation proteins
AU2010281453C1 (en) 2009-07-27 2019-08-15 Takeda Pharmaceutical Company Limited Blood coagulation protein conjugates
GB2488532B (en) * 2011-02-18 2013-06-05 Sca Ipla Holdings Inc Communication units and methods for control change notification in broadcast communication

Also Published As

Publication number Publication date
CA2836103C (en) 2020-07-14
JP6863950B2 (ja) 2021-04-21
US20120329072A1 (en) 2012-12-27
PT2710375T (pt) 2019-05-08
PL2710375T3 (pl) 2019-07-31
WO2012159084A1 (en) 2012-11-22
TR201904997T4 (tr) 2019-05-21
DK3517956T3 (da) 2021-10-11
JP2023081972A (ja) 2023-06-13
PL3517956T3 (pl) 2021-12-20
ES2893605T3 (es) 2022-02-09
JP7618714B2 (ja) 2025-01-21
JP7242627B2 (ja) 2023-03-20
US8785139B2 (en) 2014-07-22
ES2720138T3 (es) 2019-07-18
EP3943939A1 (en) 2022-01-26
JP2019035765A (ja) 2019-03-07
DK2710375T3 (en) 2019-04-29
PT3517956T (pt) 2021-10-15
EP2710375A1 (en) 2014-03-26
EP3517956A1 (en) 2019-07-31
AU2012255066A1 (en) 2013-05-02
JP2021063816A (ja) 2021-04-22
CA2836103A1 (en) 2012-11-22
AU2012255066B2 (en) 2016-06-02
JP2014524010A (ja) 2014-09-18
JP2017161536A (ja) 2017-09-14
EP3517956B1 (en) 2021-09-08
AU2016203387A1 (en) 2016-06-16
AU2016203387B2 (en) 2018-01-25
EP2710375B1 (en) 2019-03-13

Similar Documents

Publication Publication Date Title
JP7242627B2 (ja) 修飾依存的活性アッセイ
JP2014524010A5 (enExample)
JP2010025941A (ja) 抗フォン・ビルビラント因子切断プロテアーゼ（ａｄａｍｔｓ１３）抗体のための診断アッセイ
CN114217067A (zh) 一种SARS-CoV-2抗体的定量检测方法
AU2008313688A1 (en) EDTA resistant S100A12 complexes (ERAC)
JP2006524321A5 (enExample)
CN102947705A (zh) 通过确定焦谷氨酸修饰的mcp-1诊断炎性疾病的方法和谷氨酰胺酰基环化酶抑制剂的筛选方法
HK40067577A (en) Modification-dependent activity assays
HK40010723B (en) Modification-dependent activity assays
HK40010723A (en) Modification-dependent activity assays
JP7128827B2 (ja) 固定分析物
US20240353431A1 (en) Selective measurement of human factor viii
JPS6113156A (ja) ヒトインタ−フエロン−αの定量用試薬及び定量法
JP2569196B2 (ja) 抗ヒト・ｓｌｐｉ抗体およびヒト・ｓｌｐｉの免疫測定法
EP3177312B1 (en) Method and kit for detecting bacterial infection
US20050153383A1 (en) Synthetic and recombinant substrates for the detecion of the von willebrand factor-cleaving protease
Li et al. o-Phthaldehyde fluorescence microassay for the determination of antibody concentration
Hoffmann et al. Analytical methods and stability testing of biopharmaceuticals

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20150515

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20150515

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20160224

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20160301

A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20160511

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20160526

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20160608

RD03 Notification of appointment of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7423

Effective date: 20160615

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A603

Effective date: 20160729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20160729

A603 Late request for extension of time limit during examination

Free format text: JAPANESE INTERMEDIATE CODE: A603

Effective date: 20160729

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20161213

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170413

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20170619

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20170704

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20170710

R150 Certificate of patent or registration of utility model

Ref document number: 6175426

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

RD02 Notification of acceptance of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: R3D02

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250